The Osteoporosis Testing Market is projected to grow steadily through 2032, driven by the rising prevalence of osteoporosis, aging demographics, and preventive healthcare initiatives. Advances in non-invasive diagnostic technologies such as DXA, QCT, ultrasound, and portable point-of-care solutions are boosting early detection and monitoring worldwide. https://www.datamintelligence.com/research-report/osteoporosis-testing-market